flow trial semaglutide kidney outcomes 2024 nejm hazard ratio FLOWing with the SemagluTIDE — NephJC flow trial semaglutide kidney outcomes

& Zhivotovsky, B

doi: 10.1007/s13679-020-00422-w 14 ShiQWangYHaoQVandvikPOGuyattGLiJet al

For example, there have been concerns, such as: Thyroid cancer risk, especially with GLP-1 medications like Ozempic Increased chance of heart attacks or blood clots in certain individuals Worsening high blood pressure, especially when paired with other medications Hormonal shifts that could affect mood, sleep, and erectile dysfunction Anyone considering testosterone replacement therapy TRT should share their full medical history with their doctor

gently rotate the vial to mix

When GLP-1 therapy is the right call for your labs and intake, monthly costs (membership + medication at cost) average around $140-165/mo for the first 3-4 months